GENEVA, Oct. 9 -- THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE filed a patent application (US2026/022250) for “COMPOSITIONS AND METHODS FOR IN VIVO TARGETING AND REDUCTION OF CD3 GAMMA DELTA T-CELLS IN HEALTH CONDITIONS”. With publication no. WO/2026/213515, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....